203 related articles for article (PubMed ID: 21316382)
1. Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis.
Shaker ME; Zalata KR; Mehal WZ; Shiha GE; Ibrahim TM
Toxicol Appl Pharmacol; 2011 Apr; 252(2):165-75. PubMed ID: 21316382
[TBL] [Abstract][Full Text] [Related]
2. Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression.
Shaker ME; Salem HA; Shiha GE; Ibrahim TM
Fundam Clin Pharmacol; 2011 Apr; 25(2):248-57. PubMed ID: 20408881
[TBL] [Abstract][Full Text] [Related]
3. Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis.
Shaker ME; Shiha GE; Ibrahim TM
Eur J Pharmacol; 2011 Nov; 670(2-3):593-600. PubMed ID: 21925495
[TBL] [Abstract][Full Text] [Related]
4. Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats.
Sokar SS; El-Sayad ME; Ghoneim ME; Shebl AM
Biomed Pharmacother; 2017 May; 89():98-107. PubMed ID: 28222401
[TBL] [Abstract][Full Text] [Related]
5. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.
Shiha GE; Abu-Elsaad NM; Zalata KR; Ibrahim TM
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):788-97. PubMed ID: 25115651
[TBL] [Abstract][Full Text] [Related]
6. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl₄-treated rats.
Clichici S; Olteanu D; Nagy AL; Oros A; Filip A; Mircea PA
J Med Food; 2015 Mar; 18(3):290-8. PubMed ID: 25133972
[TBL] [Abstract][Full Text] [Related]
7. Silymarin decreases connective tissue growth factor to improve liver fibrosis in rats treated with carbon tetrachloride.
Tzeng JI; Chen MF; Chung HH; Cheng JT
Phytother Res; 2013 Jul; 27(7):1023-8. PubMed ID: 22933420
[TBL] [Abstract][Full Text] [Related]
8. Protective mechanism of salvia miltiorrhiza on carbon tetrachloride-induced acute hepatotoxicity in rats.
Lee TY; Mai LM; Wang GJ; Chiu JH; Lin YL; Lin HC
J Pharmacol Sci; 2003 Mar; 91(3):202-10. PubMed ID: 12686743
[TBL] [Abstract][Full Text] [Related]
9. Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis.
Jeong DH; Lee GP; Jeong WI; Do SH; Yang HJ; Yuan DW; Park HY; Kim KJ; Jeong KS
World J Gastroenterol; 2005 Feb; 11(8):1141-8. PubMed ID: 15754394
[TBL] [Abstract][Full Text] [Related]
10. Protective mechanism of andrographolide against carbon tetrachloride-induced acute liver injury in mice.
Ye JF; Zhu H; Zhou ZF; Xiong RB; Wang XW; Su LX; Luo BD
Biol Pharm Bull; 2011; 34(11):1666-70. PubMed ID: 22040877
[TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats.
Abdel Salam OM; Sleem AA; Shafee N
Inflammopharmacology; 2010 Apr; 18(2):87-94. PubMed ID: 20069380
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of yam on carbon tetrachloride-induced hepatic fibrosis in rats.
Chan YC; Chang SC; Liu SY; Yang HL; Hseu YC; Liao JW
J Sci Food Agric; 2010 Jan; 90(1):161-7. PubMed ID: 20355026
[TBL] [Abstract][Full Text] [Related]
13. Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1.
Peng WH; Tien YC; Huang CY; Huang TH; Liao JC; Kuo CL; Lin YC
J Ethnopharmacol; 2010 Feb; 127(3):606-13. PubMed ID: 20035854
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effect of trans-Chalcone on experimentally induced hepatic injury in rats: inhibition of hepatic inflammation and fibrosis.
Singh H; Sidhu S; Chopra K; Khan MU
Can J Physiol Pharmacol; 2016 Aug; 94(8):879-87. PubMed ID: 27191034
[TBL] [Abstract][Full Text] [Related]
15. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.
Shaaban AA; Shaker ME; Zalata KR; El-kashef HA; Ibrahim TM
Chem Biol Interact; 2014 Jan; 207():81-91. PubMed ID: 24144775
[TBL] [Abstract][Full Text] [Related]
16. Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride.
Omar ZMM; Ahmed AA; El-Bakry MH; Ahmed MA; Hasan A
Ann Pharm Fr; 2022 Sep; 80(5):659-668. PubMed ID: 35093389
[TBL] [Abstract][Full Text] [Related]
17. Hepatoprotective effect of Scoparia dulcis on carbon tetrachloride induced acute liver injury in mice.
Tsai JC; Peng WH; Chiu TH; Huang SC; Huang TH; Lai SC; Lai ZR; Lee CY
Am J Chin Med; 2010; 38(4):761-75. PubMed ID: 20626061
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vitamin E, L-carnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress.
Shaker ME; Houssen ME; Abo-Hashem EM; Ibrahim TM
J Physiol Biochem; 2009 Sep; 65(3):225-33. PubMed ID: 20119817
[TBL] [Abstract][Full Text] [Related]
19. In vivo hepatic oxidative stress because of carbon tetrachloride toxicity: protection by melatonin and pinoline.
Aranda M; Albendea CD; Lostalé F; López-Pingarrón L; Fuentes-Broto L; Martínez-Ballarín E; Reiter RJ; Pérez-Castejón MC; García JJ
J Pineal Res; 2010 Aug; 49(1):78-85. PubMed ID: 20524971
[TBL] [Abstract][Full Text] [Related]
20. Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats.
Ahmed AF; Mahmoud MF; Ouf MA; El-Fathaah EA
Ann Hepatol; 2011; 10(2):207-15. PubMed ID: 21502683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
